ATE151987T1 - Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl - Google Patents

Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl

Info

Publication number
ATE151987T1
ATE151987T1 AT92110637T AT92110637T ATE151987T1 AT E151987 T1 ATE151987 T1 AT E151987T1 AT 92110637 T AT92110637 T AT 92110637T AT 92110637 T AT92110637 T AT 92110637T AT E151987 T1 ATE151987 T1 AT E151987T1
Authority
AT
Austria
Prior art keywords
pyridazinone
platele
counts
reduce
atom
Prior art date
Application number
AT92110637T
Other languages
English (en)
Inventor
Mitsuyoshi Nakashima
Nobuyuki Kikuchi
Misao Miyamoto
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of ATE151987T1 publication Critical patent/ATE151987T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT92110637T 1991-07-05 1992-06-24 Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl ATE151987T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3165670A JPH0517357A (ja) 1991-07-05 1991-07-05 血小板減少療法剤

Publications (1)

Publication Number Publication Date
ATE151987T1 true ATE151987T1 (de) 1997-05-15

Family

ID=15816796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92110637T ATE151987T1 (de) 1991-07-05 1992-06-24 Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl

Country Status (6)

Country Link
US (1) US5219854A (de)
EP (1) EP0521381B1 (de)
JP (1) JPH0517357A (de)
AT (1) ATE151987T1 (de)
CA (1) CA2073117A1 (de)
DE (1) DE69219219T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2147841T3 (es) * 1994-01-25 2000-10-01 Nissan Chemical Ind Ltd Derivados de piridazinona.
EP0665223A1 (de) * 1994-01-28 1995-08-02 Takeda Chemical Industries, Ltd. Antitumormittel, 3(2H)-Pyridazinon-Derivate und ihre Herstellung
US6103740A (en) * 1997-08-21 2000-08-15 Eli Lilly And Company Methods for lowering platelet counts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201765B1 (de) * 1985-04-27 1991-09-18 Nissan Chemical Industries Ltd. 3(2H) Pyridazinone, Verfahren zu ihrer Herstellung und diese enthaltende anti-allergische Mittel
US4978665A (en) * 1987-01-20 1990-12-18 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it

Also Published As

Publication number Publication date
EP0521381A1 (de) 1993-01-07
DE69219219D1 (de) 1997-05-28
CA2073117A1 (en) 1993-01-06
US5219854A (en) 1993-06-15
DE69219219T2 (de) 1997-08-14
EP0521381B1 (de) 1997-04-23
JPH0517357A (ja) 1993-01-26

Similar Documents

Publication Publication Date Title
EP1035123A4 (de) Neue heterozyklische verbindungen
KR0138695B1 (en) Nitrogenous heterocyclic compound c 07 d 235/00
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
DE69012840D1 (de) Adenosin-Derivate, die eine Aktivität gegen Bluthochdruck haben.
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
LV11897B (lv) Silīciju saturoši fungicīdu savienojumi, to pagatavošana un agroķīmiskā un medicīniskā pielietošana
DK0464604T3 (da) 1-indolylalkyl-4-(alkoxypyrimidinyl)piperaziner
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE3462894D1 (de) 3-indolecarboxamide compounds
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
DK0476854T3 (da) Farmaceutisk komposition til at hæmme blodpladeaggregation
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
ATE36325T1 (de) Derivate von 5-halovinyl-2'-deoxyuridin.
EP0201349A3 (de) Tetrazolderivate
NO872874D0 (no) Amid-derivater.
DE69405999D1 (de) Pharmazeutisch wirksame enantiomere
KR890009886A (ko) 심기능 부전의 예방 및 치료제
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
TW275629B (de)
EP0919233B8 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
DE3884878D1 (de) Uricosuretische Zusammensetzung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties